Introducing AITRICS, a medical startup solving inefficiencies in intensive care with its proprietary AI (Artificial Intelligence) technology.
AITRICS, a medical software company,
announces VitalCare, an early detection and prevention management solution for
use in Intensive Care Units (ICU).
VitalCare is a suite of software that
monitors the electronic medical records of a patient in real-time. Therefore,
it detects and prognoses potential risks involving an acute form of
pyelonephritis, pulmonary embolism, sudden cardiac arrest, or sepsis in
advance, to mitigate or significantly reduce the rate of mortality.
The product was developed through years of
collaborative research and development efforts with Yonsei Medical Center, one
of the nation’s premier research hospitals.
At the core, it enables an
“Uncertainty-Aware” attention mechanism using a proprietary artificial
intelligence engine. It consists of unique Bayesian Deep-Learning and
Meta-Learning techniques. These techniques are employed to accomplish high
accuracy in an uncertainty model development with a minimum data learning
intervention. Recognized for its high performance, its underpinning technology
in the product is well received by the Conference on Neural Information
Processing Systems (NeurlIPS) and International Conference on Machine Learning
(ICML), which are considered internationally renowned authorities on AI.
In a recent Covid-19 outbreak, the infected
patients exhibited a range of symptoms with different lapses of time.
Early-stage proactive detection increases the chance of recovery but
considerably diminishes if left untreated for a prolonged period.
Similarly, in the case of sepsis, early
prognosis is critical. However, if the disease-causing pathogen can't be
discovered in time, this could lead to severe irreversible internal damage and
side effects and worse death of a patient.
AITRICS founder and the CEO, Jin-Gyu Yu
believes with his company’s solution, “VitalCare can potentially reverse this
situation through shortening and accelerating the process while gaining greater
accuracy in diagnosis. It further provides treatment recommendations as well as
an optimized prescription guideline for which could increase the possibility of
patient survival in critical conditions. Reduced unnecessary medical expenses
are likewise an added benefit. For attending doctors and medical staff, VitalCare
will improve their productivity with fewer errors and ultimately provide a
superior quality of service.” Jin-Gyu said that “AITRICS will continually
develop and improve its AI capabilities to provide a trusted solution for the
medical professional.”
AITRICS has recently established a
collaboration with Cleveland Clinic to validate VitalCare's performance.
Utilizing the vast amount of clinical data, AITRICS intends to verify the
accuracy and fine-tune the model parameters in its product. With this software,
the company is aiming to gain a better handle on patients at a critical time
and support Cleveland Clinic to optimize its use of resources at the same time.
Eventually, AITRICS will proceed with a plan to gradually expand the study into
other areas of disease upon successful completion of the test. AITRICS has
taken an initial step forward with its US partner and is now preparing for FDA
approval.
Jin-Gyu is excited that “AITRICS will focus
on integrating AI technology to other applications for creating practical
solutions in the near future and is allowed to assist the public in gaining
easier access to experience AI in action. Obviously, AI cannot solve every
problem, but it can definitely help in solving existing issues that couldn’t be
solved before or offer reasonable values for labor-intensive industries.
Currently, AITRICS is challenging problems ahead in the healthcare market
through honing and applying its technical skills and will continue to pave ways
to prove countless possibilities.”
Upon obtaining approval for regulatory
compliance, AlTrics will concentrate its efforts to commercialize products and
accelerate solution development for new drug discovery.
Meanwhile, AITRICS will proactively engage
with the medical community, local municipalities, and academia regularly to
promote the value of AI technologies.
About AITRICS:
